Medical Developments International Ltd (ASX:MVP)’s stock price was up 4.9% on Monday . The company traded as high as A$6.05 ($4.29) and last traded at A$6.05 ($4.29), approximately 132,578 shares traded hands during mid-day trading. The stock had previously closed at A$5.77 ($4.09).
The business’s 50-day simple moving average is A$5.41 and its two-hundred day simple moving average is A$5.34. The company has a current ratio of 4.21, a quick ratio of 3.81 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $391.68 million and a PE ratio of 373.13.
Medical Developments International Company Profile (ASX:MVP)
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians.
Read More: FAANG Stocks
Receive News & Ratings for Medical Developments International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Developments International and related companies with MarketBeat.com's FREE daily email newsletter.